Arrhythmia Alliance News & Events
Discontinuation of Sale and Distribution of Coumadin (Warfarin Sodium) Tablets for oral use
Bristol-Myers Squibb announced that the sale and distribution of all strengths of Coumadin (Warfarin Sodium) tablets will be discontinued in the United States, Canada, Latin America, and Saudi Arabia, due to an unexpected manufacturing issue.
This action is voluntary and is not the result of any quality, safety or efficacy issues regarding the product, but rather due to an unexpected manufacturing issue that cannot be resolved.
The discontinuation of this product in the U.S.A. happened on April 24th, 2020.
For more, click here